ACEI/ARB
ACEI/ARB is a pharmaceutical drug with 9 clinical trials. Currently 4 active trials ongoing. Historical success rate of 75.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
4
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy
Finerenone Therapy for Pediatric HSPN With Mild Proteinuria
Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM)
Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study
Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).
Clinical Trials (9)
Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy
Finerenone Therapy for Pediatric HSPN With Mild Proteinuria
Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM)
Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study
Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).
A Cohort Study to Compare the Hospitalization Between Naive Sacubitril/Valsartan and Naive ACEi/ARBs Heart Failure Patients With Reduced Ejection Fraction Using Secondary US Electronic Health Records Data
ACEI or ARB and COVID-19 Severity and Mortality in US Veterans
Effect of Angiotensin-Neprilysin Inhibition (ARNI) on Prognosis of Chronic Heart Failure
Registry for Ambulant Therapy With RAS-Inhibitors in Hypertension-patients in Germany
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9